More than 25% of cancers are rare, yet they receive only 1% of research funding. This year, the Jedi community helped launch a new way to close that gap. Your year-end gift keeps the momentum going.
Give by card, bank, PayPal, Apple Pay or Google Pay. Have a donor-advised fund? Choose DAFpay | Donor Advised Funds at checkout.
Give now Other ways to giveIn January, the Alliance for Rare Cancers (ARC), the collaborative our foundation founded and fiscally sponsors, launched the Rare Cancer Data Initiative with the Case Comprehensive Cancer Center and the Rare Cancer Research Foundation.
Two-year pilot grant from the Chan Zuckerberg Initiative's Biohub
Rare brain cancers and sarcomas being studied
Single-cell profiles generated
2026 pilot milestone met
We would not have that funding if it were not for the Jedi community.
Gifts to the Jedi Rare Cancer Foundation laid the groundwork for the ideas that won the Biohub grant. The data the pilot generates is shared openly with researchers, building a foundation for finding treatments that work across rare tumor types.
ARC is extending the pilot into an Ultra-Rare Cancer Network of physicians, patients and advocacy groups, starting with ultra-rare sarcomas and brain tumors.
ARC has met all first-year goals and is in active discussions with partners about funding a larger second phase of the initiative.
This year we welcomed Executive Director Samantha J. Silver, ARC CEO Ben Geyerhahn and ARC Program Officer Dr. Erin Siegel to carry the work forward.
Grants like Biohub's fund the science, but not the people who win and manage them. Our core team runs on an annual budget of under $400,000, and this year alone it submitted nearly $10 million in grant proposals while managing the Biohub pilot.
Your year-end gift keeps that team in place, so every dollar you give can help bring in many more.
Jed Taxel was diagnosed with a rare cancer in 2017 and passed just six months later. In his memory, his family and friends founded the Jedi Rare Cancer Foundation with a single mission: to accelerate the scientific discovery that changes lives for people with rare cancers.
Choose an amount on the form above, select DAFpay | Donor Advised Funds, and sign in to your DAF provider to recommend the grant.
Search for Jed Ian Taxel Foundation for Rare Cancer Research or EIN 86-2610819. In the grant note, write “Year-End 2026.”
Make your check payable to The Jed Ian Taxel Foundation for Rare Cancer Research and mail it to P.O. Box 683501, Park City, UT 84068-3501.
Legal name: The Jed Ian Taxel Foundation for Rare Cancer Research, Inc.
EIN: 86-2610819
Status: 501(c)(3) nonprofit organization
Questions: Mark Taxel, Founder and Chairman, 914-671-4766 or [email protected]; Samantha J. Silver, Executive Director, [email protected]
Thank you. Together, we can END rare cancer.